Locations:
Search IconSearch

Cancer

chronic kidney disease
April 12, 2019/Cancer/Tumor Oncology

Metastatic Non-Clear Cell Renal Cancer Patients Have Positive Response to Immunotherapy

Analysis provides evidence to guide treatment of uncommon RCC subtypes

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

nci-vol-3696_650x450
March 25, 2019/Cancer/Blood Cancers

Azacitidine Shows Potential in Treating AML and MDS Relapse Following Stem Cell Transplantation

May offer much needed treatment option for patients who relapse early

TFRT_650x450
March 22, 2019/Cancer/News & Insight

Time-to-Treat, Two Years Later

Our Cancer Center Chair reflects on progress and potential

18-LRI-265-silvermanAZA-650×450

Pathway that Mediates Cytotoxicity of AZA Discovered

What we know so far about the OAS-RNase L innate immune pathway

BackPage 61 of 140Next

Advertisement

Ad